Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

1.

Prevalence estimation of celiac disease in the general adult population of Latvia using serology and HLA genotyping.

Leja M, Shums Z, Nikitina-Zake L, Gavars M, Kikuste I, Milo J, Daugule I, Pahomova J, Pirags V, Dzerve V, Klovins J, Erglis A, Norman GL.

United European Gastroenterol J. 2015 Apr;3(2):190-9. doi: 10.1177/2050640615569379.

2.

Iodine deficiency during pregnancy: a national cross-sectional survey in Latvia.

Konrade I, Kalere I, Strele I, Makrecka-Kuka M, Jekabsone A, Tetere E, Veisa V, Gavars D, Rezeberga D, Pīrāgs V, Lejnieks A, Dambrova M.

Public Health Nutr. 2015 Mar 3:1-8. [Epub ahead of print]

PMID:
25731595
3.

A cross-sectional survey of urinary iodine status in Latvia.

Konrade I, Neimane L, Makrecka M, Strele I, Liepinsh E, Lejnieks A, Vevere P, Gruntmanis U, Pīrāgs V, Dambrova M.

Medicina (Kaunas). 2014;50(2):124-9. doi: 10.1016/j.medici.2014.06.003. Epub 2014 Jun 27.

4.

Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.

Abols A, Ducena K, Zayakin P, Silina K, Kalnina Z, Sadovska L, Tars J, Vilmanis J, Narbuts Z, Eglitis J, Pirags V, Line A.

Cancer Biomark. 2014;14(5):361-9. doi: 10.3233/CBM-140413.

PMID:
25171478
5.

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.

Yale JF, Bakris G, Cariou B, Nieto J, David-Neto E, Yue D, Wajs E, Figueroa K, Jiang J, Law G, Usiskin K, Meininger G; DIA3004 Study Group.

Diabetes Obes Metab. 2014 Oct;16(10):1016-27. doi: 10.1111/dom.12348. Epub 2014 Jul 22.

PMID:
24965700
6.

The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy.

Fouqueray P, Pirags V, Diamant M, Schernthaner G, Lebovitz HE, Inzucchi SE, Bailey CJ.

Diabetes Care. 2014 Jul;37(7):1924-30. doi: 10.2337/dc13-2349. Epub 2014 Apr 10.

PMID:
24722500
7.

The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia.

Bordeleau L, Yakubovich N, Dagenais GR, Rosenstock J, Probstfield J, Chang Yu P, Ryden LE, Pirags V, Spinas GA, Birkeland KI, Ratner RE, Marin-Neto JA, Keltai M, Riddle MC, Bosch J, Yusuf S, Gerstein HC; ORIGIN Trial Investigators.

Diabetes Care. 2014 May;37(5):1360-6. doi: 10.2337/dc13-1468. Epub 2014 Feb 26.

PMID:
24574355
8.

The role of common and rare MC4R variants and FTO polymorphisms in extreme form of obesity.

Rovite V, Petrovska R, Vaivade I, Kalnina I, Fridmanis D, Zaharenko L, Peculis R, Pirags V, Schioth HB, Klovins J.

Mol Biol Rep. 2014 Mar;41(3):1491-500. doi: 10.1007/s11033-013-2994-4. Epub 2014 Jan 3.

PMID:
24385306
9.

Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects.

Rosen JB, Jimenez JG, Pirags V, Vides H, Massaad R, Hanson ME, Brudi P, Triscari J.

Lipids Health Dis. 2013 Jul 16;12:103. doi: 10.1186/1476-511X-12-103.

10.

Polymorphisms in FTO and near TMEM18 associate with type 2 diabetes and predispose to younger age at diagnosis of diabetes.

Kalnina I, Zaharenko L, Vaivade I, Rovite V, Nikitina-Zake L, Peculis R, Fridmanis D, Geldnere K, Jacobsson JA, Almen MS, Pirags V, Schiöth HB, Klovins J.

Gene. 2013 Sep 25;527(2):462-8. doi: 10.1016/j.gene.2013.06.079. Epub 2013 Jul 13.

PMID:
23860325
11.

Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients.

Skapare E, Konrade I, Liepinsh E, Strele I, Makrecka M, Bierhaus A, Lejnieks A, Pirags V, Dambrova M.

J Diabetes Complications. 2013 May-Jun;27(3):262-7. doi: 10.1016/j.jdiacomp.2012.12.002. Epub 2013 Jan 23.

PMID:
23351995
12.

A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease.

Rosen JB, Jimenez JG, Pirags V, Vides H, Hanson ME, Massaad R, McPeters G, Brudi P, Triscari J.

Diab Vasc Dis Res. 2013 May;10(3):277-86. doi: 10.1177/1479164112465212. Epub 2013 Jan 3.

13.

The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.

Jimenez JG, Rosen JB, Pirags V, Massaad R, Hanson ME, Brudi P, Triscari J.

Diabetes Obes Metab. 2013 Jun;15(6):513-22. doi: 10.1111/dom.12059. Epub 2013 Jan 25.

PMID:
23279632
14.

Identification of glyoxalase 1 polymorphisms associated with enzyme activity.

Peculis R, Konrade I, Skapare E, Fridmanis D, Nikitina-Zake L, Lejnieks A, Pirags V, Dambrova M, Klovins J.

Gene. 2013 Feb 15;515(1):140-3. doi: 10.1016/j.gene.2012.11.009. Epub 2012 Nov 29.

PMID:
23201419
15.

The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy.

Fouqueray P, Pirags V, Inzucchi SE, Bailey CJ, Schernthaner G, Diamant M, Lebovitz HE.

Diabetes Care. 2013 Mar;36(3):565-8. doi: 10.2337/dc12-0453. Epub 2012 Nov 16.

16.

Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.

Leja M, Cine E, Rudzite D, Vilkoite I, Huttunen T, Daugule I, Rumba-Rozenfelde I, Pimanov S, Liepniece-Karele I, Pahomova J, Purmalis K, Eglitis J, Pirags V, Dzerve V, Erglis A.

Eur J Gastroenterol Hepatol. 2012 Dec;24(12):1410-7. doi: 10.1097/MEG.0b013e3283583ca5.

PMID:
23114744
17.

Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings.

Pīrāgs V, El Damassy H, Dąbrowski M, Gönen MS, Račická E, Martinka E, Giaconia J, Stefanski A; B001 Study Investigators.

Int J Clin Pract. 2012 Nov;66(11):1033-41. doi: 10.1111/j.1742-1241.2012.03001.x. Erratum in: Int J Clin Pract. 2013 Jun;67(6):e1.

PMID:
23067027
18.

Seasonal iodine deficiency in Latvian school children.

Konrade I, Dambrova M, Makrecka M, Neimane L, Strele I, Liepinsh E, Lejnieks A, Vevere P, Gruntmanis U, Pirags V.

Thyroid. 2012 Oct;22(10):1088-9. doi: 10.1089/thy.2011.0506. Epub 2012 Sep 4. No abstract available.

PMID:
22947352
19.

Seasonal iodine deficiency in Latvian school children.

Konrade I, Dambrova M, Makrecka M, Neimane L, Strele I, Liepinsh E, Lejnieks A, Vevere P, Gruntmanis U, Pīrāgs V.

Thyroid. 2012 Jul 5. [Epub ahead of print]

PMID:
22765259
20.

Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.

Tarasova L, Kalnina I, Geldnere K, Bumbure A, Ritenberga R, Nikitina-Zake L, Fridmanis D, Vaivade I, Pirags V, Klovins J.

Pharmacogenet Genomics. 2012 Sep;22(9):659-66. doi: 10.1097/FPC.0b013e3283561666.

PMID:
22735389
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk